FDA advisers recommend approval of controversial ALS drug – The Washington Post

Business News

  1. FDA advisers recommend approval of controversial ALS drug  The Washington Post
  2. FDA panel backs Massachusetts company’s much-debated ALS drug in rare, 2nd review  WCVB Boston
  3. AMLX stock drives RETA stock, ARDX stock higher amid AdCom vote on ALS drug (NASDAQ:RETA)  Seeking Alpha
  4. In reversal, FDA panel votes to recommend experimental ALS drug  NBC News
  5. FDA panel backs much-debated ALS drug in rare, 2nd review  The Associated Press
  6. View Full Coverage on Google News

Source: Business News

/by